Crispr Cas9 Comertial Kit

Cas9 Protein and T7 gRNA SmartNuclease Synthesis Kit
CAS400A-KIT SBI 1 kit (10 rxn) 1332 EUR

Abmgood Laboratories manufactures the crispr cas9 comertial kit reagents distributed by Genprice. The Crispr Cas9 Comertial Kit reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact ABMgood. Other Crispr products are available in stock. Specificity: Crispr Category: Cas9 Group: Comertial Kit

Rabbit True insulin ELISA kit
BlueGene 96T 700 EUR
Description: ELISA

Canine True insulin ELISA kit
BlueGene 96T 700 EUR
Description: ELISA

Monkey True insulin ELISA kit
BlueGene 96T 700 EUR
Description: ELISA

Mouse True insulin ELISA kit
BlueGene 96T 700 EUR
Description: ELISA

Rat True insulin ELISA kit
BlueGene 96T 700 EUR
Description: ELISA

Sheep True insulin ELISA kit
BlueGene 96T 700 EUR
Description: ELISA

Bovine True insulin ELISA kit
BlueGene 96T 700 EUR
Description: ELISA

Comertial Kit information

TIGIT CRISPR/Cas9 Lentivirus (Integrating)
78058 BPS Bioscience 500 µl x 2 795 EUR
Description: TIGIT (T-cell immunoreceptor with Ig and ITIM domains; VSTM3; VSIG9) is a co-inhibitory receptor that is highly expressed in Natural Killer (NK) cells and activated CD4+, CD8+, and regulatory T-cells. Interaction with the Poliovirus Receptor (PVR; CD155) on antigen presenting cells, such as dendritic cells, recruits either the Src homology (SH) domain-containing tyrosine phosphatases SHP1 and SHP2, or the Inositol phosphatase SHIP1 and SHIP2, to the TIGIT ITIM domain. This increases IL-10 release and suppresses NF-κB and NFAT T-cell receptor (TCR) signaling, which blocks T-cell proliferation and cytokine production. TIGIT also serves as a competitive inhibitor of CD226, a costimulatory receptor for CD155. TIGIT-targeting antibodies which block this T-cell intrinsic inhibitory effect have shown enhanced anti-tumor and anti-viral functions in preclinical studies._x000D_
The TIGIT CRISPR Lentiviruses are replication incompetent, HIV-based VSV-G pseudo-typed lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a CRISPR/Cas9 gene driven by an EF1a promoter, along with 4 sgRNA (single guide RNA) targeting human TIGIT (GenBank Accession #NM_173799) driven by a U6 promoter._x000D_
The integrating lentivirus integrates randomly into the cell's genome to express both the Cas9 and sgRNA. Puromycin selection increases the knockout efficiency by forcing high expression levels of both Cas9 and the sgRNA, and can be used with the integrating lentivirus to quickly and easily achieve high knockdown efficiencies in a cell pool. Efficiencies also depend on the cell type and the gene of interest.

NLRP3 CRISPR/Cas9 Lentivirus (Integrating)
78545 BPS Bioscience 500 µl x 2 995 EUR
Description: NLR family Pyrin domain containing 3 (NLRP3) is expressed in macrophages and is a component of inflammasomes. NLRP3 detects uric acid and extracellular ATP in damaged tissue and interacts with a pro-apoptotic protein that recruits caspases. This complex is also an upstream activator of NF-κB signaling and triggers an immune response as part of the innate immune system. Mutations in NLRP3 are known to cause autoinflammatory and neuroinflammatory diseases, such as Alzheimer's, Parkinson's, and prion disease. The NLRP3 CRISPR/Cas9 Lentiviruses are replication incompetent, HIV-based VSV-G pseudo-typed lentiviral particles ready to infect most types of mammalian cells, including primary and non-dividing cells. The particles contain a CRISPR/Cas9 gene driven by an EF1a promoter, along with 5 sgRNA (single guide RNA) targeting human NLRP3 (Figure 1 and Table 1), allowing the knockdown of NLRP3 in transduced cells.The DNA transduced by the integrating lentivirus integrates randomly into the cellular genome to express both Cas9 and sgRNA. Puromycin selection increases the knockout efficiency by forcing high expression levels of both Cas9 and the sgRNA, and can be used with the integrating lentivirus to quickly and easily achieve high knockdown efficiencies in a cell pool. Knockdown efficiencies also depend on the cell type.

CRISPR-Associated Endonuclease Cas9/Csn1 (Cas9) Antibody
abx340123-100ug Abbexa 100 ug 469.2 EUR

CRISPR-Associated Endonuclease Cas9/Csn1 (Cas9) Antibody
abx340123-10mg Abbexa 10 mg Ask for price

CRISPR-Associated Endonuclease Cas9/Csn1 (Cas9) Antibody
abx340123-1mg Abbexa 1 mg 337.5 EUR

FCGR2A CRISPR/Cas9 Lentivirus (Integrating)
78537 BPS Bioscience 500 µl x 2 795 EUR
Description: Fc Gamma Receptor 2A (also known as CD32A, Fc-gamma-RIIa, FcgRIIa) is a low affinity Fc receptor for immunoglobulin G, encoded by the FCGR2A gene. Fc Gamma Receptor 2A is a cell surface receptor that is expressed on a variety of immune cells such as macrophages and neutrophils. It is involved in phagocytosis and in the clearing of spent immune complexes from the circulation. A polymorphism in FCGR2A has been associated with increased risks of nephritis and lupus.The FCGR2A CRISPR/Cas9 Lentiviruses are replication incompetent, HIV-based VSV-G pseudo-typed lentiviral particles that are ready to transduce into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a CRISPR/Cas9 gene driven by an EF1a promoter, along with 5 sgRNA (single guide RNA) targeting human FCGR2A.

Mouse Anti- CRISPR/Cas9 [7A9-3A3]
MBS375383-002mg MyBiosource 0.02mg 335 EUR

Mouse Anti- CRISPR/Cas9 [7A9-3A3]
MBS375383-005mg MyBiosource 0.05mg 485 EUR

Mouse Anti- CRISPR/Cas9 [7A9-3A3]
MBS375383-01mg MyBiosource 0.1mg 560 EUR

Mouse Anti- CRISPR/Cas9 [7A9-3A3]
MBS375383-5x01mg MyBiosource 5x0.1mg 2305 EUR

KIT sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
K1152305 ABM 3 x 1.0 ug 451.2 EUR

Kit sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
K4860905 ABM 3 x 1.0 ug 451.2 EUR

Comt sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
K6779405 ABM 3 x 1.0 ug 451.2 EUR

Comp sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
K6910605 ABM 3 x 1.0 ug 451.2 EUR

COMP sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
K0488005 ABM 3 x 1.0 ug 451.2 EUR

COMT sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
K0488105 ABM 3 x 1.0 ug 451.2 EUR

Commd7 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
K7188105 ABM 3 x 1.0 ug 451.2 EUR